The Effects of Peanut Oral Immunotherapy on Food Allergy Related Quality of Life

2012 ◽  
Vol 129 (2) ◽  
pp. AB29 ◽  
Author(s):  
J.M. Factor ◽  
M.R. Lester ◽  
L.M. Mendelson ◽  
J.O. Lee ◽  
J. Sproviero ◽  
...  

2020 ◽  
Vol 145 (2) ◽  
pp. AB136
Author(s):  
Justin Greiwe ◽  
William Lavery ◽  
Jonathan Bernstein ◽  
Umesh Singh


Author(s):  
Vibha Szafron ◽  
Sara Anvari ◽  
Grant Pickett ◽  
Kristen A. Staggers ◽  
Charles G. Minard ◽  
...  


2020 ◽  
Vol 23 ◽  
pp. S731
Author(s):  
N. Afroz ◽  
J. Marvel ◽  
C. Naujoks ◽  
D. Ossa ◽  
F. Patalano


2016 ◽  
Vol 137 (2) ◽  
pp. AB256
Author(s):  
Linda Herbert ◽  
Elizabeth Flory ◽  
Hemant P. Sharma




2021 ◽  
Vol 126 (1) ◽  
pp. 83-88.e1
Author(s):  
Jennifer L.P. Protudjer ◽  
Michael Golding ◽  
Marlee R. Salisbury ◽  
Elissa M. Abrams ◽  
Leslie E. Roos


Children ◽  
2018 ◽  
Vol 5 (6) ◽  
pp. 70
Author(s):  
Alicia Widge ◽  
Elizabeth Flory ◽  
Hemant Sharma ◽  
Linda Herbert


Author(s):  
Victoria Thörnqvist ◽  
Roelinde Middelveld ◽  
Hay Mar Wai ◽  
Natalia Ballardini ◽  
Evalill Nilsson ◽  
...  




2021 ◽  
Vol 42 (2) ◽  
pp. 118-123
Author(s):  
Aikaterini Anagnostou

Food allergies are common and affect 6‐8% of children in the United States; they pose a significant burden on the quality of life of children with allergy and their caregivers due to multiple daily restrictions. Despite the recommended dietary avoidance, reactions tend to occur due to unintentional exposure to the allergenic food trigger. Fear of accidental ingestions with potentially severe reactions, including anaphylaxis and death, creates anxiety in individuals with food allergy. Oral immunotherapy has emerged as a form of active and potentially disease-modifying treatment for common food allergies encountered in childhood. The efficacy of oral immunotherapy is high, with the majority of participants achieving desensitization and, as a result, protection from trace exposures and improved quality of life. The main risk of oral immunotherapy consists of allergic reactions to treatment. In general, rates of allergic reactions and anaphylaxis are reported to be higher in individuals pursuing therapy options, but most subjects who undergo oral immunotherapy will likely experience mild or moderate reactions during treatment. Adverse events tend to reduce in both frequency and number in the maintenance period. The use of immune modulators alongside oral immunotherapy has been suggested, with the aim to improve efficacy and safety, and to facilitate the overall process. It is evident that the landscape of food allergy management is changing and that the future looks brighter, with different options emerging over time. The process of how to choose the appropriate option becomes a discussion between the clinician and the patient, which involves a joint review of the current medical evidence but also the patient's preference for balancing particular attributes of the treatment. By working together, providers and patients will ensure achievement of the best possible outcome for children with food allergies.



Sign in / Sign up

Export Citation Format

Share Document